These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6455942)

  • 1. D-tryptophan-6-LH-RH-at los doses in the treatment of male subfertility.
    Levalle O; Tropea L; Aparicio N; Guitelman A; Mancini A; Schally AM; Schally V
    Andrologia; 1981; 13(3):207-11. PubMed ID: 6455942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Tryptophan-6-luteinizing hormone-releasing hormone in the treatment of normogonadotropic oligoasthenozoospermia.
    Schwarzstein L; Aparicio NJ; Schally AV
    Int J Androl; 1982 Apr; 5(2):171-8. PubMed ID: 6213567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-leucine-6-luteinizing hormone-releasing hormone ethylamide in the treatment of normogonadotropic oligoasthenospermia.
    Schwarzstein L; Aparicio NJ; Turner D; De Turner EA; Premoli F; Schally AV
    Fertil Steril; 1978 Mar; 29(3):332-5. PubMed ID: 346384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of luteinizing hormone and follicle-stimulating hormone to different doses of D-leucine-6-LH-RH ethylamide in oligospermic patients.
    Turner D; Turner EA; Aparicio NJ; Schwarzstein L; Coy DH; Schally AV
    Fertil Steril; 1976 May; 27(5):545-8. PubMed ID: 776707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons.
    Lewis RW; Dowling KJ; Schally AV
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2975-9. PubMed ID: 3157995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
    Szende B; Srkalovic G; Groot K; Lapis K; Schally AV
    Cancer Res; 1990 Jun; 50(12):3716-21. PubMed ID: 2160323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of pulsatile luteinizing hormone-releasing hormone administration selectively decreases follicle-stimulating hormone levels in men with idiopathic azoospermia.
    Gross KM; Matsumoto AM; Berger RE; Bremner WJ
    Fertil Steril; 1986 Mar; 45(3):392-6. PubMed ID: 3081382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent blockade of the pituitary-gonadal axis in patients with prostatic carcinoma during chronic administration of D-Trp-6-LH-RH.
    Gonzalez-Barcena D; Perez-Sanchez P; Berea-Dominguez H; Graef-Sanchez A; Becerril-Morales M; Comaru-Schally AM; Schally AV
    Prostate; 1986; 9(2):207-15. PubMed ID: 2944084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone.
    Torres-Aleman I; Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1252-6. PubMed ID: 2858096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary and testicular response to LH-RH and to a long-acting analogue (D-leu-6-LH-RH-ethylamide).
    Schwarzstein L; Aparicio NJ; Turner D; de Turner EA; Schally AV; Coy DH
    Andrologia; 1978; 10(1):59-65. PubMed ID: 343641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of gonadotropins with and without a GnRH analogue (D6-tryptophan) in male infertility due to idiopathic oligoasthenospermia.
    Luciano A; Fascella A; Lo Meo C; Palisi F; Dones F; Tiberio C
    Acta Eur Fertil; 1992; 23(5):225-31. PubMed ID: 1343183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial with D-Trp-6-LH-RH in prostatic carcinoma: comparison with other hormonal agents.
    Mathé G; Schally AV; Comaru-Schally AM; Mauvernay RY; Vovan ML; Machover D; Misset JL; Court B; Bouchard P; Duchier J
    Prostate; 1986; 9(4):327-42. PubMed ID: 2947053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term, pulsatile, low dose, subcutaneous luteinizing hormone-releasing hormone administration in men with idiopathic oligozoospermia. Failure of therapeutic and hormonal response.
    Fauser BC; Rolland R; Dony JM; Corbey RS
    Andrologia; 1985; 17(2):143-9. PubMed ID: 3923865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of idiopathic normogonadotropic oligoasthenospermia with synthetic luteinizing hormone-releasing hormone.
    Aparicio NJ; Schwarzstein L; Turner EA; Turner D; Mancini R; Schally AV
    Fertil Steril; 1976 May; 27(5):549-55. PubMed ID: 776708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental ovarian carcinoma with monthly injection of the agonist D-Trp-6-LH-RH: a preliminary report.
    Pour PM; Redding TW; Paz-Bouza JI; Schally AV
    Cancer Lett; 1988 Jul; 41(1):105-10. PubMed ID: 2968836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypogonadotropic hypogonadal male patients with the luteinizing hormone-relasing hormone (LH-RH) anolog D-Ser(TBU)6 EA10 LH-RH: transient disappearance of gonadotropin stimulation.
    Morel Y; Fournier M; Mazenod B; Tourniaire J; Mornex R
    Fertil Steril; 1982 Jul; 38(1):85-91. PubMed ID: 6807722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.
    Schally AV; Kook AI; Monje E; Redding TW; Paz-Bouza JI
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8764-8. PubMed ID: 2946045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of precocious puberty with LH-RH agonists. Multicenter study using D-Trp-6-LH-RH in a programmed-release form].
    Roger M; Chaussain JL; Bost M; Bozzola M; Colle M; Despert F; François R; Freycon F; Garandeau P; Malpuech G
    Rev Fr Gynecol Obstet; 1986 May; 81(5):297-305. PubMed ID: 2943013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of Dunning R-3327H prostate cancer model.
    Redding TW; Schally AV
    Prostate; 1985; 6(3):219-32. PubMed ID: 3157927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.